Melinda O’Connor

Epigenetic therapy for <scp>F</scp>riedreich ataxia

Elisabetta Soragni, Wenyan Miao, Marco Iudicello et al. · Annals of Neurology · 2014 · 142 citations · Full text

A phase 3, multicenter, randomized, double-blind, placebo-controlled, safety, tolerability, and efficacy study of Xtampza ER in patients with moderate-to-severe chronic low back pain

Nathaniel P. Katz, Ernest A. Kopecky, Melinda O’Connor et al. · Pain · 2015 · 35 citations

Pain Therapy, Pain Disorders, Pain Medicine +28

Oral Human Abuse Potential of Oxycodone DETERx^®(Xtampza^®ER)

Ernest A. Kopecky, Alison B. Fleming, Naama Levy‐Cooperman et al. · The Journal of Clinical Pharmacology · 2016 · 30 citations · Full text

Tolerability, Safety, and Effectiveness of Oxycodone DETERx in Elderly Patients ≥65 Years of Age with Chronic Low Back Pain: A Randomized Controlled Trial

Ernest A. Kopecky, Ben Vaughn, Scott Lagasse et al. · Drugs & Aging · 2017 · 12 citations · Full text

The Comparative Pharmacokinetics of Physical Manipulation by Crushing of Xtampza ^® ER Compared with OxyContin ^®

Michael J. Brennan, Ernest A. Kopecky, Ann Marseilles et al. · Pain Management · 2017 · 11 citations · Full text